The failings at a Baltimore, US factory making Johnson & Johnson's COVID-19 vaccine mean that millions of doses of the shot will have to be jettisoned, according to an FDA update.
The fallout over the FDA's decision to approved Biogen's Alzheimer's therapy Aduhelm continues to be felt, with a third member of its advisory committee resigning in protest.
Ocugen is the first company to be affected by the FDA's recent decision to raise the bar on emergency use authorisations for COVID-19 medicines, and will have to file for full approval of i
The unexpected approval and lofty pricing of Biogen's Alzheimer's therapy Aduhelm is clearly the biopharma event of the year so far, but what are the broader implications for the industry a
Pfizer has the FDA approval it was seeking for Prevnar 20, the latest update to its blockbuster pneumococcal vaccination franchise, keeping it one step ahead of a competing shot from Merck